John Iskander
Impact in
- Toxicology top 0.2%
- Pharmacovigilance and Adverse Drug Reactions
- Virology top 10%
Papers in
- Toxicology 20
- Pharmacovigilance and Adverse Drug Reactions 20
-
- Diphtheria, Corynebacterium, and Tetanus 2
- Co-authors
- Robert Ball (8 shared papers)M. Miles Braun (7 shared papers)Frederick E. Varricchio (3 shared papers)Robert Pless (1 shared paper)Frank R. Destefano (1 shared paper)Robert T. Chen (1 shared paper)Penina Haber (5 shared papers)Emily Jane Woo (5 shared papers)
- Journals
- Vaccine (6 papers)PEDIATRICS (4 papers)MMWR Morbidity and Mortality Weekly Report (3 papers)Drug Safety (2 papers)The Pediatric Infectious Disease Journal (2 papers)
- Partner nations
- United StatesUgandaKenya
In The Last Decade
John Iskander
24 papers receiving 974 citations
Peers
Comparison fields: 5 of 66
- Toxicology 433
- Virology 56
- Immunology and Allergy 49
- Health 64
- Epidemiology 211
Countries citing papers authored by John Iskander
This map shows the geographic impact of John Iskander's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Iskander with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Iskander more than expected).
Fields of papers citing papers by John Iskander
This network shows the impact of papers produced by John Iskander. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Iskander. The network helps show where John Iskander may publish in the future.
Co-authors
The 25 scholars most cited alongside John Iskander, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 317 | |
| 2 | 2008 | 99 | |
| 3 | 2005 | 77 | |
| 4 | 2017 | 71 | |
| 5 | 2005 | 60 | |
| 6 | 2007 | 50 | |
| 7 | 2009 | 47 | |
| 8 | 2006 | 37 | |
| 9 | 2009 | 36 | |
| 10 | 2009 | 30 | |
| 11 | 2009 | 29 | |
| 12 | 2009 | 26 | |
| 13 | 2017 | 26 | |
| 14 | 2010 | 24 | |
| 15 | 2010 | 22 | |
| 16 | 2015 | 21 | |
| 17 | 2008 | 19 | |
| 18 | Monitoring vaccine safety during an influenza pandemic. | 2005 | 16 |
| 19 | 2011 | 15 | |
| 20 | 2004 | 10 |
About John Iskander
John Iskander is a scholar working on Toxicology, Endocrinology, Virology, Epidemiology and Clinical Biochemistry, having authored 24 papers that have together received 1.1k indexed citations. Recurring topics across this work include Pharmacovigilance and Adverse Drug Reactions (20 papers), Influenza Virus Research Studies (3 papers), Diphtheria, Corynebacterium, and Tetanus (2 papers), Cervical Cancer and HPV Research (1 paper), Rabies epidemiology and control (1 paper), Prenatal Substance Exposure Effects (1 paper), Migraine and Headache Studies (1 paper) and Metabolism and Genetic Disorders (1 paper). The work is most often cited by research in Toxicology (433 citations), Virology (56 citations), Immunology and Allergy (49 citations), Health (64 citations) and Epidemiology (211 citations). John Iskander has collaborated with scholars based in United States, Uganda and Kenya. Frequent co-authors include Robert Ball, M. Miles Braun, Frederick E. Varricchio, Robert Pless, Frank R. Destefano, Robert T. Chen, Penina Haber, Emily Jane Woo, Sean V. Shadomy and Héctor S. Izurieta. Their work appears in journals such as Vaccine, PEDIATRICS, MMWR Morbidity and Mortality Weekly Report, Drug Safety and The Pediatric Infectious Disease Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.